MIREN
TELLERÍA ARRIETA
Investigadora hasta 2022
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (7)
2024
2021
-
Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry
International Journal of Cardiology, Vol. 338, pp. 63-71
-
Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis
Cardiovascular Revascularization Medicine, Vol. 31, pp. 1-6
2020
-
Estrategias de tratamiento antitrombótico en pacientes mayores de 75 años con fibrilación auricular tras intervencionismo coronario percutáneo con stents farmacoactivos: Registro PACO-PCI
REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 322-323
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
2017
-
Antithrombotic treatment during coronary angioplasty after failed thrombolysis: Strategies and prognostic implications. Results of the RESPIRE registry
BMC Cardiovascular Disorders, Vol. 17, Núm. 1
2016
-
The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study
Catheterization and Cardiovascular Interventions, Vol. 87, Núm. 2, pp. 262-269